Global Drug–Device Combination Products Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Drug–Device Combination Products

• 1.1 Definition of Drug–Device Combination Products
• 1.2 Drug–Device Combination Products Segment by Type
  • 1.2.1 Global Drug–Device Combination Products Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Infusion Pumps
  • 1.2.3 Orthopedic Combination Products
  • 1.2.4 Photodynamic Therapy Devices
  • 1.2.5 Transdermal Patches
  • 1.2.6 Drug Eluting Stents
  • 1.2.7 Wound Care Products
  • 1.2.8 Inhalers
  • 1.2.9 Other
• 1.3 Drug–Device Combination Products Segment by Applications
  • 1.3.1 Global Drug–Device Combination Products Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Other
• 1.4 Global Drug–Device Combination Products Overall Market
  • 1.4.1 Global Drug–Device Combination Products Revenue (2014-2025)
  • 1.4.2 Global Drug–Device Combination Products Production (2014-2025)
  • 1.4.3 North America Drug–Device Combination Products Status and Prospect (2014-2025)
  • 1.4.4 Europe Drug–Device Combination Products Status and Prospect (2014-2025)
  • 1.4.5 China Drug–Device Combination Products Status and Prospect (2014-2025)
  • 1.4.6 Japan Drug–Device Combination Products Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Drug–Device Combination Products Status and Prospect (2014-2025)
  • 1.4.8 India Drug–Device Combination Products Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Drug–Device Combination Products
• 2.3 Manufacturing Process Analysis of Drug–Device Combination Products
• 2.4 Industry Chain Structure of Drug–Device Combination Products

3 Development and Manufacturing Plants Analysis of Drug–Device Combination Products

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Drug–Device Combination Products Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Drug–Device Combination Products
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Drug–Device Combination Products Production and Capacity Analysis
• 4.2 Drug–Device Combination Products Revenue Analysis
• 4.3 Drug–Device Combination Products Price Analysis
• 4.4 Market Concentration Degree

5 Drug–Device Combination Products Regional Market Analysis

• 5.1 Drug–Device Combination Products Production by Regions
  • 5.1.1 Global Drug–Device Combination Products Production by Regions
  • 5.1.2 Global Drug–Device Combination Products Revenue by Regions
• 5.2 Drug–Device Combination Products Consumption by Regions
• 5.3 North America Drug–Device Combination Products Market Analysis
  • 5.3.1 North America Drug–Device Combination Products Production
  • 5.3.2 North America Drug–Device Combination Products Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Drug–Device Combination Products Import and Export
• 5.4 Europe Drug–Device Combination Products Market Analysis
  • 5.4.1 Europe Drug–Device Combination Products Production
  • 5.4.2 Europe Drug–Device Combination Products Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Drug–Device Combination Products Import and Export
• 5.5 China Drug–Device Combination Products Market Analysis
  • 5.5.1 China Drug–Device Combination Products Production
  • 5.5.2 China Drug–Device Combination Products Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Drug–Device Combination Products Import and Export
• 5.6 Japan Drug–Device Combination Products Market Analysis
  • 5.6.1 Japan Drug–Device Combination Products Production
  • 5.6.2 Japan Drug–Device Combination Products Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Drug–Device Combination Products Import and Export
• 5.7 Southeast Asia Drug–Device Combination Products Market Analysis
  • 5.7.1 Southeast Asia Drug–Device Combination Products Production
  • 5.7.2 Southeast Asia Drug–Device Combination Products Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Drug–Device Combination Products Import and Export
• 5.8 India Drug–Device Combination Products Market Analysis
  • 5.8.1 India Drug–Device Combination Products Production
  • 5.8.2 India Drug–Device Combination Products Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Drug–Device Combination Products Import and Export

6 Drug–Device Combination Products Segment Market Analysis (by Type)

• 6.1 Global Drug–Device Combination Products Production by Type
• 6.2 Global Drug–Device Combination Products Revenue by Type
• 6.3 Drug–Device Combination Products Price by Type

7 Drug–Device Combination Products Segment Market Analysis (by Application)

• 7.1 Global Drug–Device Combination Products Consumption by Application
• 7.2 Global Drug–Device Combination Products Consumption Market Share by Application (2014-2019)

8 Drug–Device Combination Products Major Manufacturers Analysis

• 8.1 Abbott
  • 8.1.1 Abbott Drug–Device Combination Products Production Sites and Area Served
  • 8.1.2 Abbott Product Introduction, Application and Specification
  • 8.1.3 Abbott Drug–Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Terumo Corporation
  • 8.2.1 Terumo Corporation Drug–Device Combination Products Production Sites and Area Served
  • 8.2.2 Terumo Corporation Product Introduction, Application and Specification
  • 8.2.3 Terumo Corporation Drug–Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Stryker Corporation
  • 8.3.1 Stryker Corporation Drug–Device Combination Products Production Sites and Area Served
  • 8.3.2 Stryker Corporation Product Introduction, Application and Specification
  • 8.3.3 Stryker Corporation Drug–Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Mylan
  • 8.4.1 Mylan Drug–Device Combination Products Production Sites and Area Served
  • 8.4.2 Mylan Product Introduction, Application and Specification
  • 8.4.3 Mylan Drug–Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Medtronic
  • 8.5.1 Medtronic Drug–Device Combination Products Production Sites and Area Served
  • 8.5.2 Medtronic Product Introduction, Application and Specification
  • 8.5.3 Medtronic Drug–Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Allergan
  • 8.6.1 Allergan Drug–Device Combination Products Production Sites and Area Served
  • 8.6.2 Allergan Product Introduction, Application and Specification
  • 8.6.3 Allergan Drug–Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Boston Scientific
  • 8.7.1 Boston Scientific Drug–Device Combination Products Production Sites and Area Served
  • 8.7.2 Boston Scientific Product Introduction, Application and Specification
  • 8.7.3 Boston Scientific Drug–Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Novartis
  • 8.8.1 Novartis Drug–Device Combination Products Production Sites and Area Served
  • 8.8.2 Novartis Product Introduction, Application and Specification
  • 8.8.3 Novartis Drug–Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 C.R. Bard
  • 8.9.1 C.R. Bard Drug–Device Combination Products Production Sites and Area Served
  • 8.9.2 C.R. Bard Product Introduction, Application and Specification
  • 8.9.3 C.R. Bard Drug–Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Teleflex Incorporated
  • 8.10.1 Teleflex Incorporated Drug–Device Combination Products Production Sites and Area Served
  • 8.10.2 Teleflex Incorporated Product Introduction, Application and Specification
  • 8.10.3 Teleflex Incorporated Drug–Device Combination Products Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Drug–Device Combination Products Market

• 9.1 Global Drug–Device Combination Products Market Trend Analysis
  • 9.1.1 Global Drug–Device Combination Products Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Drug–Device Combination Products Regional Market Trend
  • 9.2.1 North America Drug–Device Combination Products Forecast 2019-2025
  • 9.2.2 Europe Drug–Device Combination Products Forecast 2019-2025
  • 9.2.3 China Drug–Device Combination Products Forecast 2019-2025
  • 9.2.4 Japan Drug–Device Combination Products Forecast 2019-2025
  • 9.2.5 Southeast Asia Drug–Device Combination Products Forecast 2019-2025
  • 9.2.6 India Drug–Device Combination Products Forecast 2019-2025
• 9.3 Drug–Device Combination Products Market Trend (Product Type)
• 9.4 Drug–Device Combination Products Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Drug–Device Combination Products Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List